Tempus Launches AI Prostate Test for Advanced Cancer
Chicago, Illinois, USA – May 21, 2026 Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced...
cardiac innovation
Advertisement
Bayer Gains FDA Priority Review for Kerendia
WHIPPANY, N.J., May 21, 2026 Bayer has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
Reflow Medical Reports Positive Six-Month Spur Elute Coronary Study Results
SAN CLEMENTE, Calif., May 20, 2026 Reflow Medical, Inc. has announced encouraging six-month clinical results from its DEEPER CORONARY...
FDA Clears Anteris PARADIGM Trial for DurAVR Heart Valve
Minneapolis, USA, and Brisbane, Australia – November 3, 2025 Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) has announced...
Advertisement
